CDC -Laboratory Resources - HAI

CDC -Laboratory Resources - HAI

Laboratory Resources

How to Submit HAI Isolates and Specimens

Fact sheets

• Quinolones and the Clinical Laboratory
• Vancomycin-resistant Enterococci (VRE) and the Clinical Laboratory
• Laboratory Detection of Extended-Spectrum β-Lactamases (ESBLs)
• Laboratory Detection of Imipenem or Meropenem Resistance in Gram-negative Organisms
• Laboratory Detection of Oxacillin/Methicillin-resistant Staphylococcus aureus

Laboratory Testing and Practices (Protocols that partners can use)

Detection of Antimicrobial Resistance

Gram Negative Bacteria

• Unified Pulsed-Field Gel Electrophoresis (PFGE) Protocol for Gram Positive Bacteria  [PDF 78 KB]
• Modified Pulse-Net Procedure for Pulsed-field Gel Electrophoresis of Select Gram Negative Bacilli  [PDF - 408 KB]

Duodenoscope Sampling

• First Review: Interim Duodenoscope Surveillance Protocol
• Interim Duodenoscope Sampling Method
• Interim Duodenoscope Culture Method
• FAQs on the Interim Duodenoscope Surveillance Protocol

Enterobacteriaceae

• Multiplex Real-Time PCR Detection of Klebsiella pneumoniae Carbapenemase (KPC) and New Delhi metallo-β-lactamase (NDM-1) genes May, 2011
• Modified Hodge Test for Carpenamase Detection in Enterobacteriaceace  [PDF 127 KB]
• Laboratory Protocol for Detection of Carbapenem-Resistant or Carbapenamase-Producing, Klebsiellaspp. and E. coli from Rectal Swabs  [PDF 110 KB] December, 2008

Staphylococci

• Investigation and Control of Vancomycin-Resistant Staphylococcus aureus (VRSA)  [PDF - 300 KB]
• CDC. Use of an Inferred PFGE Algorithm, Emerging Infections Program/Active Bacterial Core (ABCs) Surveillance Invasive MRSA Project
• CDC. Laboratory detection of vancomycin-intermediate/resistant staphylococcus aureus (VISA/VRSA).
• CDC Reminds Clinical Laboratories and Healthcare Infection Preventionists of their Role in the Search and Containment of VRSA
• CDC. Laboratory detection of coagulase-negative staphylococcus species with decreased susceptibility to the glycopeptides vancomycin and teicoplanin.
• CDC. PulseNet. Oxacillinresistant staphylococcus aureus on PulseNet (OPN): laboratory protocol for molecular typing of S. aureus by pulsed-field gel electrophoresis (PFGE).  [PDF - 499 KB]

Laboratory Safety Publications

• CDC. Biosafety in microbiological and biomedical laboratories (BMBL).
• CDC. Interim laboratory biosafety guidance for extensively drug-resistant (XDR) mycobacterium tuberculosis strains
• World Health Organization (WHO); 2004. Laboratory biosafety manual. 
• World Health Organization (WHO); 2006. Biorisk management: laboratory biosecurity guidance. 

Additional Resources

• Baughman W, Farley M, Toomey K, et al. Laboratory capacity to detect antimicrobial resistance, 1998. MMWR 2000;48(51);1167–71.
• CDC. Staphylococcus aureus with Reduced Susceptibility to Vancomycin — United States, 1997.  [PDF - 267 KB] MMWR 1997;46(33).
• Defining the public health impact of drug-resistant Streptococcus pneumoniae. Appendix. Laboratory-based surveillance system. MMWR 1996;45(RR-1);15–20.
• E. coli O157:H7: Procedure for Isolation and Identification from Stool Specimens. MMWR 1994